Canadian Sec - Delayed Quote • CAD Promino Nutritional Sciences Inc. (MUSL.CN) Follow Compare 0.0600 -0.0050 (-7.69%) At close: January 17 at 3:46:42 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Promino Nutritional Sciences Inc. Provides Shareholder Progress Report Burlington, Ontario--(Newsfile Corp. - December 11, 2024) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") is pleased to present a progress report highlighting the Company's major milestones and developments achieved in the second half of 2024. Promino Chief Executive Officer Vito Sanzone said, "This period has been a transformational one for Promino, as we have made significant strides expanding our product offering, establishing a global Promino Nutritional Sciences Inc. Further Expands U.S. and Canada Distribution with Three Partners Representing Over 40,000 New Doors Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") announces it has added three new distribution partners to expand North American distribution of its patented essential amino acid products Rejuvenate Muscle Activator™ and Promino™ - NSF Certified for Sport®. Promino Nutritional Sciences Inc. Continues Expansion of International Distribution Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") today announced Initial product orders from Vigor Nation to distribution Rejuvenate™ and Promino™ across the Caribbean region, reaching millions of potential active nutrition supplement consumers. Furthermore, the Company has entered into a letter of intent with Altanzaan LLC, one of the largest sports nutrition distributors in Mongolia, to make Rejuvenate and Promino available to millions of Promino Nutritional Sciences Inc. Adds E-commerce Retailer Netrition.com to Boost U.S. and International distribution of Rejuvenate Muscle Activator™ Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") announces it has added Netrition.com as a distribution partner to provide Rejuvenate Muscle Activator™ to health and wellness consumers globally. Promino Nutritional Sciences Inc. Begins Preclinical Trial to Demonstrate Effectiveness of Promino™ Patented IP for Retention of Muscle Mass in Cancer Patients Undergoing Aggressive Chemotherapy Treatment Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") has announced the commencement of the preclinical trial to demonstrate the effectiveness of the Promino™ patented IP for the retention of muscle mass in cancer patients undergoing aggressive chemotherapy treatment. The preclinical trial will be led by Dr. Patrick Gunning, who was appointed as special advisor to the Company on May 8, 2024 to conduct these trials. Promino Nutritional Sciences Inc. Lands International Exclusivity for Patented Muscle Health IP to Launch Ready-to-Drink Products in 2025 Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") has reached an agreement with the licensor of the patented muscle health blend (the "Patent") used in the Company's Rejuvenate Muscle Activator™ and Promino™ products on an exclusive international rights provision for the RTD market, and strengthens the current terms for the powdered supplement business. Under the terms of the agreement dated September 5, 2024, Promino must invest US$1 millio Promino Nutritional Sciences Inc.: New Clinical Study Confirms A 3.6 gram Serving of Rejuvenate Muscle Activator™ Produces the Equivalent Muscle Protein Synthesis as 40 grams of Whey Protein Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") today announced the release of results of a new human clinical trial led by Dr. Robert R. Wolfe, Phd. The trial found that a 3.6 gram serving of Rejuvenate Muscle Activator™ has the same effect on muscle protein synthesis as 40 grams of whey protein. Promino Nutritional Sciences, Inc. Improves Fundamentals, Expands Retail and E-commerce Distribution of Promino™- Certified for Sport® and Rejuvenate Muscle Activator™ Across North America, and Marks Further Strategic Milestones Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") today highlights the Company's continued progress in its plan to increase revenue and expand consumer acceptance of its patented functional beverage brands. Promino Nutritional Sciences Inc. Partners with iHerb to Distribute Promino™ and Rejuvenate Muscle Activator™ Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") announces today that iHerb has listed its Promino™ and Rejuvenate Muscle Activator™ brands. Promino Nutritional Sciences Inc. Announces Debut of Rejuvenate Muscle Activator™ at Nearly 300 Jean Coutu Pharmacies Across Canada and Provides Corporate Update Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") today announces that it has shipped its all-new Rejuvenate Muscle Activator™ drink mix in Raspberry Burst and Citrus Blast to nearly 300 Jean Coutu stores across Canada, marking critical expansion of the brand's availability in Quebec, New Brunswick and Ontario. Promino Nutritional Sciences Inc. Announces Promino™ and Rejuvenate Muscle Activator™ Brands Debut on The Kroger Co.'s vitacost.com Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X)( the "Company" or "Promino")(www.drinkpromino.com) today announced that the all-new Promino™ and Rejuvenate Muscle Activator™ products released in July are now featured on www.vitacost.com, the Boca Raton, Florida-based e-commerce retailer owned by The Kroger Co. Promino Nutritional Sciences Inc. Reaches New Milestone by Activating Direct-To-Consumer Sites drinkpromino.dom and rejuvenatemuscle.com Promino Nutritional Sciences, Inc (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) ( the "Company" or "Promino") (www.drinkpromino.com) today announced the activation of both their Rejuvenate Muscle Health™ and Promino™ direct-to-consumer (DTC) sites, effective today. Promino Nutritional Sciences Inc. to Receive 65,000 Total Units Of New Rejuvenate Muscle Health™ And Promino™, Achieves Another Key Comeback Milestone On Schedule Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X)( the "Company" or "Promino")(www.drinkpromino.com) today announces it has achieved another key milestone in its turnaround plan. PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE Promino Nutritional Sciences, Inc. (CSE: MUS) (OTC: MUSLF) (FRANKFURT: 93X) ( the "Company" or "Promino") (www.drinkpromino.com) today provides a corporate update on significant milestones achieved in the last nine months. PROMINO NUTRITIONAL SCIENCES INC. SIGNS AGREEMENT WITH LAS VEGAS LIGHTS FC OF USL CHAMPIONSHIP TO MAKE PROMINO™ "THE OFFICIAL PROTEIN DRINK OF THE LAS VEGAS LIGHTS" Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) ( the "Company" or "Promino")(www.drinkpromino.com) has signed a three-year agreement with the USL Championship side Las Vegas Lights FC to become "The Official Protein Drink of the Las Vegas Lights," beginning in the 2025 season. Promino Nutritional Sciences to Conduct Preclinical Trials Evaluating Promino's Effectiveness in Fighting Muscle Loss Caused by Ozempic and other GLP- 1 Based Weight Loss Treatments Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino")(www.drinkpromino.com), today announced that Dr. Patrick Gunning will assess the results of preclinical trials with various GLP-1 drugs and Promino in murine obesity models to improve muscle mass retention during weight loss. Promino Nutritional Sciences and Dr. Patrick Gunning to Begin Preclinical Studies Focused on Targeted Nutritional Supplementation for Cancer Patients Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") is pleased to announce it has retained award winning PhD Dr. Patrick Gunning to assess preclinical studies conducted on its patented formulation's mitigation of muscle loss in cancer patients. Dr. Gunning will be joining the Company as a special advisor on various preclinical studies over the next 12 months. PROMINO NUTRITIONAL SCIENCES ACCELERATES REJUVENATE MUSCLE ACTIVATOR™ E-COMMERCE EXPANSION AHEAD OF JUNE RELAUNCH Promino Nutritional Sciences Inc (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or Promino") (www.drinkpromino.com) announces e-commerce listing activity on Amazon, Walmart.com, and eBay ahead of the June relaunch of Rejuvenate Muscle Activator™, one of the Company's flagship drink mix brands. PROMINO NUTRITIONAL SCIENCES WELCOMES SIX TIME MLB ALL-STAR JOSÉ BAUTISTA AS BRAND AMBASSADOR Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT:93X) (the "Company" or "Promino") is pleased to announce José Bautista will join the firm as a brand ambassador for Promino's patented protein beverages later this year. WORLD-RENOWNED CHIROPRACTOR DR. MARK LINDSAY JOINS PROMINO NUTRITIONAL SCIENCES AS ATHLETIC ADVISOR; PROVIDES CORPORATE UPDATE Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") is pleased to announce world-renowned chiropractor, soft tissue specialist and PhD in Neuroscience at Queens University, Dr. Mark Lindsay, one of the most sought-after therapists amongst elite athletes, will join as our corporate advisor focused on professional athletics. Performance Overview Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return MUSL.CN S&P/TSX Composite index YTD 0.00% +1.82% 1-Year -78.95% +19.67% 3-Year -94.74% +17.37%